NCT06072417View on ClinicalTrials.gov

HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)

NAActive, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 22, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Pulmonary Vascular DiseasePulmonary Artery HypertensionChronic Thromboembolic Pulmonary Hypertension
Interventions
OTHER

Assessment without intervention at High altitude

Assessments at High altitude corresponding to Baseline measures

OTHER

Relocation to sea level for 2 days

Participants will be relocated to sea level and intervention and have assessements there.

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER